Company Filing History:
Years Active: 2022
Title: The Innovations of Danni Harris: Pioneering Neuropeptide S Receptor Agonists
Introduction: Danni Harris, an accomplished inventor based in Boonville, California, has made significant contributions to the field of pharmacology with her innovative work on neuropeptide S receptor agonists. With one patent under her name, her research addresses critical disorders that affect mental health and cognitive function, showcasing her dedication to advancing therapeutic options.
Latest Patents: Danni Harris holds a patent for Neuropeptide S receptor (NPSR) agonists. This innovative patent describes the synthesis and application of trimeric, tetrameric, pentameric, and hexameric peptidomimetic analogs that exhibit unique affinity for and activity at the neuropeptide S receptor. These peptidomimetic molecules hold promise for treating a variety of conditions, including substance abuse, narcolepsy, insomnia, obesity, cognitive decline, dementia, Alzheimer's disease, panic disorder, generalized anxiety, PTSD, phobias, and schizophrenia. Additionally, they may serve as supportive medication during cessation programs utilized in cognitive behavioral therapy for issues such as drug addiction, eating disorders, and gambling.
Career Highlights: Throughout her career, Danni has continued to focus on the interface between neurobiology and medical treatment, contributing to a growing understanding of how neuropeptides can shape human behavior and health. The impact of her work extends beyond her individual achievements, as it sets the stage for future innovations in therapeutic developments.
Collaborations: Danni Harris has collaborated with prominent colleagues, including Scott P. Runyon and Rainer Reinscheid, within the Research Triangle Institute. These partnerships enhance her research capabilities, allowing for a greater exploration of applications for the neuropeptide S receptor agonists and underscoring the interdisciplinary efforts necessary for groundbreaking advancements.
Conclusion: Danni Harris represents a dynamic force in the field of neurobiology and pharmacology. Her innovative patent for neuropeptide S receptor agonists exemplifies her commitment to addressing complex health challenges. As she continues her work at the Research Triangle Institute, the potential for her inventions to change lives remains significant, providing hope for new treatments and therapies in mental health care.